- Home
- TXG vs AZTA Comparison
TXG vs AZTA Comparison
Compare TXG & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- AZTA
- Stock Information
- Founded
- TXG 2012
- AZTA 1978
- Country
- TXG United States
- AZTA United States
- Employees
- TXG N/A
- AZTA N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- AZTA Industrial Machinery/Components
- Sector
- TXG Industrials
- AZTA Technology
- Exchange
- TXG Nasdaq
- AZTA Nasdaq
- Market Cap
- TXG 1.6B
- AZTA 1.4B
- IPO Year
- TXG 2019
- AZTA 1995
- Fundamental
- Price
- TXG $12.86
- AZTA $30.46
- Analyst Decision
- TXG Buy
- AZTA Buy
- Analyst Count
- TXG 12
- AZTA 4
- Target Price
- TXG $13.54
- AZTA $42.00
- AVG Volume (30 Days)
- TXG 2.2M
- AZTA 471.4K
- Earning Date
- TXG 10-28-2025
- AZTA 11-11-2025
- Dividend Yield
- TXG N/A
- AZTA N/A
- EPS Growth
- TXG N/A
- AZTA N/A
- EPS
- TXG N/A
- AZTA N/A
- Revenue
- TXG $644,466,000.00
- AZTA $668,821,000.00
- Revenue This Year
- TXG $2.15
- AZTA N/A
- Revenue Next Year
- TXG N/A
- AZTA $4.18
- P/E Ratio
- TXG N/A
- AZTA N/A
- Revenue Growth
- TXG 2.02
- AZTA 12.46
- 52 Week Low
- TXG $6.78
- AZTA $23.91
- 52 Week High
- TXG $24.38
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- TXG 45.60
- AZTA 50.98
- Support Level
- TXG $12.39
- AZTA $29.00
- Resistance Level
- TXG $13.39
- AZTA $31.38
- Average True Range (ATR)
- TXG 0.61
- AZTA 1.12
- MACD
- TXG -0.12
- AZTA 0.11
- Stochastic Oscillator
- TXG 21.74
- AZTA 64.60
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.